Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yee-Sin Leo and Laurent Renia.
Yee-Sin Leo
Connection Strength
1.238
Laurent Renia
  1. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Front Immunol. 2021; 12:680188.
    View in: PubMed
    Score: 0.238
  2. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19. Cell Rep Med. 2021 02 16; 2(2):100193.
    View in: PubMed
    Score: 0.231
  3. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2021 11 02; 73(9):e2932-e2942.
    View in: PubMed
    Score: 0.061
  4. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med. 2021 06 07; 13(6):e14045.
    View in: PubMed
    Score: 0.059
  5. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study. EBioMedicine. 2021 Apr; 66:103319.
    View in: PubMed
    Score: 0.059
  6. Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021 Jun; 8(6):ofab156.
    View in: PubMed
    Score: 0.059
  7. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021 Jun; 2(6):e240-e249.
    View in: PubMed
    Score: 0.058
  8. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant. Clin Transl Immunology. 2021; 10(2):e1241.
    View in: PubMed
    Score: 0.058
  9. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun. 2020 10 16; 11(1):5243.
    View in: PubMed
    Score: 0.057
  10. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020 08 29; 396(10251):603-611.
    View in: PubMed
    Score: 0.056
  11. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Clin Transl Immunology. 2020; 9(7):e1160.
    View in: PubMed
    Score: 0.056
  12. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology. 2020; 9(7):e1159.
    View in: PubMed
    Score: 0.056
  13. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine. 2020 Aug; 58:102911.
    View in: PubMed
    Score: 0.056
  14. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020 06 01; 11(1):2806.
    View in: PubMed
    Score: 0.055
  15. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity. Sci Rep. 2018 01 30; 8(1):1860.
    View in: PubMed
    Score: 0.047
  16. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012 Apr 01; 205(7):1147-54.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.